Min H. Noh
Busan, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Targeting IGF2 to reprogram the tumor microenvironment for enhanced viro-immunotherapy.
Journal: Neuro-oncology
Published: June 10, 2024
Role of Peroxiredoxin 1 Induced by Epstein-Barr Virus Infection in Nasopharyngeal Carcinoma.
Journal: Anticancer research
Published: January 05, 2024
APX‑115A, a pan‑NADPH oxidase inhibitor, reduces the degree and incidence rate of dry eye in the STZ‑induced diabetic rat model.
Journal: Experimental and therapeutic medicine
Published: October 17, 2022
Olaparib-induced Apoptosis Through EBNA1-ATR-p38 MAPK Signaling Pathway in Epstein-Barr Virus-positive Gastric Cancer Cells.
Journal: Anticancer research
Published: October 05, 2021
Effects of Epstein-Barr Virus Infection on the Response of Human Breast Cancer Cells to Nicotine.
Journal: Anticancer research
Published: May 04, 2021
Celecoxib upregulates ULBP-1 expression in lung cancer cells via the JNK/PI3K signaling pathway and increases susceptibility to natural killer cell cytotoxicity.
Journal: Oncology letters
Published: February 20, 2020
APX-115A, a pan-NADPH Oxidase Inhibitor, Induces Caspase-dependent Cell Death by Suppressing NOX4-ROS Signaling in EBV-infected Retinal Epithelial Cells.
Journal: Current eye research
Published: January 18, 2020
Combination treatment with erlotinib and ampelopsin overcomes erlotinib resistance in NSCLC cells via the Nox2-ROS-Bim pathway.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 18, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026